Erlot 150 mg Tablet
  1. Home
  2. Pharma Products
  3. Aureate Healthcare Pvt Ltd
  4. Erlot 150 mg Tablet

Erlot 150 mg Tablet

Erlot 150 mg Tablet contains erlotinib, an oral anticancer medicine used for certain types of cancer. It is mainly used in non-small cell lung cancer and pancreatic cancer. The medicine works by blocking EGFR signals that help cancer cells grow.

BUY NOW

Category

Erlot 150 mg Tablet is an EGFR tyrosine kinase inhibitor prescribed for eligible patients with locally advanced or metastatic non-small cell lung cancer and pancreatic cancer. Erlotinib helps slow cancer progression by inhibiting epidermal growth factor receptor signaling involved in tumor cell growth and survival. It is generally taken on an empty stomach, either 1 hour before or 2 hours after food, as directed by the treating oncologist. Regular medical monitoring may be required during treatment to assess response, tolerability, and possible adverse effects.

Technical Specification

Specification Details
Active Ingredient Erlotinib
Strength 150 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 30 Tablets
Marketer Aureate Healthcare Pvt Ltd

Product Also Known As

Erlot 150 mg Tablet, Erlotinib 150 mg Tablet, Erlot Erlotinib Tablet, Erlotinib Cancer Tablet, EGFR Inhibitor Tablet, Lung Cancer Treatment Tablet